SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors 24-month HOPE-3 extension data for deramiocel showed slower upper-limb decline in Duchenne muscular dystrophy patients, boosting optimism ahead of the FDA decision. Traders are debating whether the open-label results address prior FDA statistical concerns, while short-squeeze chatter remains speculative.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Citis Sell downgrade, citing valuation after Modernas sharp rally on Phase 3 melanoma-vaccine results, is driving attention. Bears see the pullback as a reality check on expectations, while bulls argue the trial and broader mRNA oncology platform still support the story ahead of detailed data.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels PrTK05 Phase 2 biomarker data showing T-cell activation after aglatimagene, alongside its reiterated plan to file a prostate-cancer BLA in Q4 2026, is driving attention. Bulls view the findings as added support for CAN-2409s mechanism and regulatory package, while skeptics say the biomarker results are limited and question filing execution, including amid concerns over the CEOs share sale and potential dilution.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoins rebound from recent support and attempts to break through overhead resistance are driving discussion, with dip buyers anticipating further gains and a possible short squeeze. Bears counter that the move may fail, pointing to resistance, elevated yields and upcoming economic data as risks.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

Cooler-than-expected PCE inflation readings and lower expectations for a Fed rate hike are supporting a short-term bounce in small caps. Traders remain divided on whether it can last, given IWMs sensitivity to Treasury yields and its recent underperformance amid high-rate concerns.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Staged IPO lockup expirations and reported insider sales are the main overhang traders associate with CBRSs sharp swings, with some also pointing to broader AI-sector and macro weakness. Bulls argue that strong AI-inference demand and customer partnerships could offset the added share supply, while bears remain concerned about selling pressure and valuation.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhoods product-summit announcementsweekend stock trading, AI trading agents, earnings-linked prediction contracts and other platform expansionsare driving attention. Traders are divided between viewing the launches as growth opportunities and criticizing the presentation or worrying about more round-the-clock speculation, while many also complain that gains quickly reversed in volatile trading.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Microns fiscal Q4 earnings and outlook are the dominant focus, with traders watching whether AI-driven HBM and DRAM demand can sustain the memory upcycle. The community is broadly optimistic about strong results but divided over whether high expectations are already priced in and whether a cyclical downturn could trigger a sell-the-news reaction.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET is drawing attention after its reported ECOC 2026 award for the Blazar photonics platform, fueling bullish momentum and short-squeeze speculation. The reaction is tempered by calls for concrete evidence of customer orders, shipments, and production progress, which many traders say matter more than awards or broad updates.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

A judges pause in the broader federal cannabis rescheduling proceeding has pressured TRLV and other cannabis stocks by delaying the expected recommendation. Many traders call the selloff an overreaction, arguing Trulieves medical-focused business is covered by a separate medical-marijuana rule, while others see the delay as a setback for broader rescheduling.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$PLTK 

Seems plan is to sell super play @$1.3B and buyer assumes $350M earn out obligation

The $1.3B will go towards paying off debt

StockTwits for iOS

Playtika Holding Corp

 

Seems plan is to sell super play @$1.3B and buyer assumes $350M earn out obligation

The $1.3B will go towards paying off debt

Zoomlik

@zoomlik or maybe just reinstate div, bcs they’ve already been allowed to issue new bonds for their loans? “Playtika Holding Corp. (PLTK) reports that its controlling shareholder has obtained approval from China’s National Development and Reform Commission (NDRC) under the 2023 Administrative Measures for the Review and Registration of Medium and Long-Term Foreign Debt of Enterprises (the “Foreign Debt Rules”). The approval permits Playtika to issue bonds in an amount not to exceed $800 million for the purpose of prepaying a portion of the principal on its outstanding term loan under the Company’s Credit Agreement dated December 10, 2019. The NDRC approval is effective through July 30, 2027 and remains subject to the applicable procedures and regulations under the Foreign Debt Rules.”

 or maybe just reinstate div, bcs they’ve already been allowed to issue new bonds for their loans? “Playtika Holding Corp. (PLTK) reports that its controlling shareholder has obtained approval from China’s National Development and Reform Commission (NDRC) under the 2023 Administrative Measures for the Review and Registration of Medium and Long-Term Foreign Debt of Enterprises (the “Foreign Debt Rules”). The approval permits Playtika to issue bonds in an amount not to exceed $800 million for the purpose of prepaying a portion of the principal on its outstanding term loan under the Company’s Credit Agreement dated December 10, 2019. The NDRC approval is effective through July 30, 2027 and remains subject to the applicable procedures and regulations under the Foreign Debt Rules.”